Homocysteine and cardiovascular disease: Overview

Journal of Cardiovascular Risk

Volumn 5, Issue 4, 1998, Pages 213-215

  Clarke, Robert ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; HUMAN; HYPERHOMOCYSTEINEMIA; PRIORITY JOURNAL; REVIEW;

CARDIOVASCULAR DISEASES; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; RISK FACTORS;

EID: 0032447205     PISSN: 13506277     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043798-199808000-00001     Document Type: Review

References (19)

1. Peto R, Lopez AD, Boreham J, Thun M, Heath C Jr. Mortality from smoking in developed countries 1950-2000. Oxford: Oxford University Press; 1994.
2. Rose G. The strategy of preventive medicine. Oxford: Oxford Medical Publications; 1992.
3. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969; 56:111-128.
4. Wilcken DEL, Wilcken B. The pathogenesis of coronary artery disease: a possible role for methionine metabolism. J Clin Invest 1976; 57:1079-1082.
5. Wilcken DE, Wilcken B. The natural history of vascular disease in homocystinuria and the effects of treatment. J Inherit Metab Dis 1997; 20:295-300.
6. Scott JM, Weir DG. The methyl folate trap. A physiological response in man to prevent methyl group deficiency in Kwashiorkor (methionine deficiency) and an explanation for folic-acid induced exacerbation of subacute combined degeneration of the cord. Lancet 1981; ii:337-340.
7. Domagala B, Undas A, Jankowski M, Libura M, Szczeklik A. Thrombin generation in hyperhomocysteinemia before and after treatment with folic acid and vitamin B-12. Thromb Haemost 1997; 530:269.
8. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991; 324:1149-1155.
9. Ueland PM, Refsum HM, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum. Methods or clinical applications. Clin Chem 1993; 39:1764-1779.
10. Boushey CJ, Beresford SA, Omen GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995; 274:1049-1057.
11. Arnesen E, Refsum H, Bonaa KH, Ueland PM, Forde OH, Nordrehaug JE, et al. Serum total homocysteine and coronary heart disease. Int J Epidemiol 1995; 24:704-709.
12. Alfthan G, Pekkanen J, Jauhiainen M, Pitkaniemi J, Karvonen M, Tuomilehto J, et al. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis 1994; 106:9-19.
13. Evans RW, Shaten BJ, Hempel JD, Cutler JA, Kuller LH. Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial. Arterioscler Thromb Vasc Biol 1997; 17:1947-1953.
14. Perry I, Refsum H, Morris RW, Ebrahim S, Ueland PM, Shaper AG. A prospective study of serum homocysteine concentration and risk of stroke in middle-aged men. Lancet 1995; 346:1395-1398.
15. Stein JH, McBride PE. Hyperhomocysteinemia and atherosclerotic vascular disease: pathophysiology, screening and treatment. Arch Intern Med 1998; 158:1301-1306.
16. Oakley GP. Eat right and take a multivitamin. N Engl J Med 1998; 338:1060-1061.
17. Omenn GS, Beresford SAA, Motulsky AG. Preventing coronary heart disease: B vitamins and homocysteine. Circulation 1998; 97:421-424.
18. Homocysteine Lowering Trialist's Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ 1998; 316:894-898.
19. Shipchandler MT, Moore EG. Rapid, fully automated measurement of plasma homocystein(e)ine with the Abbott Imx Analyzer. Clin Chem 1995; 41:991-994.